Andrea Hunt
CIK 1720487 · View on SEC EDGAR ↗
Insider
First SEC filing: Sept. 1, 2023 · Latest: Sept. 1, 2023
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 19 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 31, 2023 | GYRE | D | 28 | — | — | 0 Direct | -100.00% | Disposed | (price as of 2026-08-21) |
| Jan. 7, 2022 | GYRE | A | 7,521 | — | — | 28,228 Direct | +36.32% | Acquired | (price as of 2026-08-21) |
| Oct. 1, 2021 | GYRE | A | 1,824 | — | — | 20,707 Direct | +9.66% | Acquired | (price as of 2026-08-21) |
| July 1, 2021 | GYRE | A | 2,886 | — | — | 18,883 Direct | +18.04% | Acquired | (price as of 2026-08-21) |
| June 9, 2021 | GYRE | A | 14,000 | — | — | 14,000 Direct | — | Acquired | (price as of 2026-08-21) |
| April 1, 2021 | GYRE | A | 2,480 | — | — | 15,997 Direct | +18.35% | Acquired | (price as of 2026-08-21) |
| Jan. 5, 2021 | GYRE | A | 1,881 | — | — | 13,517 Direct | +16.17% | Acquired | (price as of 2026-08-21) |
| Oct. 1, 2020 | GYRE | A | 2,761 | — | — | 11,636 Direct | +31.11% | Acquired | (price as of 2026-08-21) |
| July 1, 2020 | GYRE | A | 2,076 | — | — | 8,875 Direct | +30.53% | Acquired | (price as of 2026-08-21) |
| June 11, 2020 | GYRE | A | 5,000 | — | — | 5,000 Direct | — | Acquired | (price as of 2026-08-21) |
| April 1, 2020 | GYRE | A | 1,673 | — | — | 6,799 Direct | +32.64% | Acquired | (price as of 2026-08-21) |
| Jan. 2, 2020 | GYRE | A | 1,073 | — | — | 5,126 Direct | +26.47% | Acquired | (price as of 2026-08-21) |
| Oct. 1, 2019 | GYRE | A | 1,489 | — | — | 4,053 Direct | +58.07% | Acquired | (price as of 2026-08-21) |
| July 1, 2019 | GYRE | A | 1,036 | — | — | 2,564 Direct | +67.80% | Acquired | (price as of 2026-08-21) |
| June 13, 2019 | GYRE | A | 5,000 | — | — | 5,000 Direct | — | Acquired | (price as of 2026-08-21) |
| April 1, 2019 | GYRE | A | 717 | — | — | 1,528 Direct | +88.41% | Acquired | (price as of 2026-08-21) |
| Dec. 31, 2018 | GYRE | A | 811 | — | — | 811 Direct | — | Acquired | (price as of 2026-08-21) |
| June 13, 2018 | GYRE | A | 5,000 | — | — | 5,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 25, 2017 | GYRE | A | 10,000 | — | — | 10,000 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 9, 2021 | GYRE | Stock Option (Right to Buy) | Common Stock (14,000) | $4.55 | June 9, 2031 | 14,000 | Acquired |
| June 11, 2020 | GYRE | Stock Option (Right to Buy) | Common Stock (5,000) | $7.18 | June 11, 2030 | 5,000 | Acquired |
| June 13, 2019 | GYRE | Stock Option (Right to Buy) | Common Stock (5,000) | $7.46 | June 13, 2029 | 5,000 | Acquired |
| June 13, 2018 | GYRE | Stock Option (Right to Buy) | Common Stock (5,000) | $24.94 | June 13, 2028 | 5,000 | Acquired |
| Oct. 25, 2017 | GYRE | Stock Option (Right to Buy) | Common Stock (10,000) | $4.72 | Oct. 25, 2027 | 10,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).